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SUMMARY – Th e aim of this review is to analyze current diagnostic approaches to obesity in 
adult men, the potential mechanisms linking obesity to infertility, and treatment options aimed at 
improving reproductive health. Obesity has become a worldwide epidemic with the estimated preva-
lence increasing from 28.8% to 36.9% between 1980 and 2013. In terms of diagnosis, numerous 
simple techniques have been developed including body mass index, waist to hip ratio, waist circumfer-
ence, bioelectrical impedance analysis, ultrasound and skinfold measurements. Additionally, several 
other less available but more accurate techniques have been suggested, such as air displacement pleth-
ysmography, dual energy x-ray absorptiometry, computed tomography and magnetic resonance imag-
ing. In addition to cardiovascular and other disorders, male obesity can negatively aff ect the male re-
productive potential through abnormal reproductive hormone levels, reduced semen quality, increased 
release of adipose-derived hormones and adipokines, as well as thermal, genetic and sexual mecha-
nisms. In the management of obesity related male infertility, natural weight loss is the cornerstone and 
regular exercise the fi rst-line treatment. Although bariatric surgery results in greater improvements in 
weight loss outcomes when compared to non-surgical interventions, further research is required to 
clarify its overall infl uence on male fertility.
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Introduction
Over the past three decades, many countries in the 
urbanized world have witnessed a growing epidemic of 
overweight and obesity. Th e epidemic is largely fueled 
by urbanization, economic growth, industrialization, 
mechanized transport, and the adoption of sedentary 
lifestyle, coupled with the high availability of foods 
with high caloric content1. Since the 1970s, the rates of 
excess body weight in reproductive-age men have 
nearly tripled, so that in westernized countries be-
tween 65% and 70% of adult men are currently over-
weight or obese. Th e estimated prevalence of over-
weight and obesity in adults worldwide has increased 
between 1980 and 2013 from 28.8% to 36.9% in men 
and from 29.8% to 38.0% in women, reaching epidem-
ic proportions with 2.1 billion adults aff ected2. Th e 
obesity epidemic has received considerable attention 
as a major global health challenge because it is associ-
ated with an increased risk of a wide array of health 
problems, including diabetes, heart disease, hyperten-
sion, cancers, as well as many digestive diseases, exert-
ing a heavy toll on the economy with its massive 
healthcare costs3.
Reproductive consequences of excess body weight 
in women have received substantial attention because 
obese women are more likely to experience ovulatory 
or menstrual disorders and delayed fertility. Th e ongo-
ing pregnancy rate/cycle among obese women was 
found to be lower than in normal weight women 
(20.8% versus 28.3%)4. Moreover, obesity has been as-
M. Kasum et al. Male obesity and fertility
302 Acta Clin Croat, Vol. 55, No. 2, 2016
sociated with an increased rate of polycystic ovary syn-
drome, infertility and treatment failure, multiple com-
plications of pregnancy including miscarriages, gesta-
tional diabetes, preeclampsia, fetal macrosomia and 
cesarean delivery with poor neonatal and maternal 
pregnancy outcomes5.
Until recently, the reproductive consequences of 
obesity on the male reproductive potential have been 
studied to a lesser extent, although it has equally been 
linked to male infertility. Th e studies reporting correla-
tions between obesity and fertility have generally been 
inconclusive because it remains unclear to what extent 
obesity aff ects the reproductive potential in men. In 
several studies, it has been suggested that overweight 
and obese men showed no signifi cantly increased rela-
tive risk of abnormal semen parameters6-8. A system-
atic review with meta-analysis of 31 studies on 6800 
men revealed little association between increased body 
mass index (BMI), average sperm concentration and 
total sperm count. Th ere was, however, strong evidence 
for a negative relationship between increased BMI and 
the levels of testosterone, sex hormone binding globu-
lin (SHBG) and free testosterone6. Th ese results sup-
port the earlier fi ndings in a study on 2139 cases where 
overweight and obese men had a markedly changed 
sex hormone profi le in serum, whereas reduction of se-
men quality was marginal7. Similarly, no signifi cant 
correlation was found between BMI and semen pa-
rameters measured in a recently published cross-sec-
tional study on 511 men8. However, since recently, it is 
being increasingly documented that male excess body 
weight has a negative impact on semen parameters9-11. 
A recent meta-analysis including 21 studies and a 
sample of 13 077 men concluded that overweight and 
obesity were associated with an increased prevalence of 
azoospermia or oligozoospermia and a signifi cantly el-
evated risk of abnormal sperm count, when compared 
with normal weight subjects9. It seems that obesity 
leads to a higher risk of sperm DNA damage in infer-
tile patients because the DNA fragmentation rate was 
found to be signifi cantly higher in obese, but not in 
overweight men10. When examining semen parame-
ters, ejaculate volume, sperm concentration and total 
sperm count were found to show linear decline with 
increasing BMI and waist circumference (WC)11. 
Moreover, erectile dysfunction and low testosterone 
are frequently accompanied by obesity, particularly 
central obesity, which can also be a cause of infertility 
or reproductive diffi  culties12. Furthermore, male obe-
sity may be associated with various comorbidities, in-
cluding metabolic syndrome, hypercholesterolemia, 
hyperleptinemia, psychological depression, sleep ap-
nea, renal failure, type 2 diabetes mellitus and cardio-
vascular diseases, all of which have independently been 
linked to male subfertility. Th erefore, it seems that the 
eff ects of male obesity and comorbidities on fertility 
are multifactorial, infl uencing sperm parameters, preg-
nancy and subsequent child health. Because it is un-
clear to what extent obesity aff ects the reproductive 
potential in men, it remains to be determined whether 
the exact eff ects occur through its higher level per se, an 
associated comorbidity, or a combination of both13. 
Th e purpose of the present review is to analyze the 
current diagnostic methods used to defi ne obesity in 
adult males, the underlying mechanisms contributing 
to male infertility, as well as the treatment options 
which may lead to improvements in reproductive 
health.
Diagnosis of Overweight and Obesity
Currently, the terms ‘overweight’ and ‘obesity’ refer 
to abnormal or excessive fat accumulation that is 
greater than what is generally considered healthy for a 
given height. Th e terms also identify ranges of weight 
that have been shown to increase the likelihood of cer-
tain diseases, as well as other health problems14.
Numerous simple and accessible anthropometric 
techniques have been developed to evaluate the body 
fat content such as BMI, waist to hip ratio (WHR), 
WC, bioelectrical impedance analysis (BIA), ultra-
sound and skinfold measurements15-23. Traditionally, 
BMI has been the most widely used method in classi-
fying overweight and obesity in adult populations be-
cause it provides a relatively good estimate of the risks 
associated with developing diseases that occur more 
frequently in people with higher body fat content. Al-
though BMI provides a signifi cantly better representa-
tion of the body fat content when compared to simply 
measuring body weight, it is only moderately corre-
lated with the body fat mass. BMI is calculated as body 




2) and it is 
the most commonly used diagnostic tool for general-
ized obesity. Despite its frequent use, BMI cannot be 
used to diff erentiate between subcutaneous and vis-
ceral fat compartments. A BMI greater than 25 kg/m2 
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is used to defi ne overweight, while a BMI over 30 kg/m2 
is characterized as obesity. Although BMI can be used 
in most individuals, it may overestimate adiposity in 
men whose higher body weight can be attributed to 
greater muscle and bone mass. However, BMI may 
also underestimate body fat in older people and others 
who have lost muscle mass. Th erefore, when BMI is 
used to indicate adiposity, gender- and age-specifi c 
thresholds should also be taken into account15,16. In ad-
dition to BMI, alternative measurements such as WC, 
WHR and to a lesser extent the waist to height ratio 
can be used to more accurately describe the distribu-
tion of body fat. Th ese methods have been suggested as 
superior to BMI in predicting health problems associ-
ated with central or visceral adiposity because abdomi-
nal or white fat tissue, rather than the total amount of 
fat, has been linked to obesity-related disorders17-19. 
WC is usually measured at the narrowest point be-
tween the lower border of the rib cage and the iliac 
crest. Men and women with WC values ≤102 and ≤88 
cm, respectively, are considered to have a normal WC, 
whereas men and women with WC values >102 and 
>88 cm, respectively, are considered to have a high 
WC17. WHR can also be used to predict serious health 
consequences as a result of increased body fat (normal 
WHR: males ≤0.9 and females <0.85)18. Although 
general and abdominal obesity measurements were 
found to be reliable predictors of obesity-related mor-
tality, evidence from a recent meta-analysis suggests 
that WC or WHR provides additional information 
that is independent to BMI and should therefore be 
used in clinical practice19. During the last decade, the 
conventional BIA, a safe and cost-effi  cient method, 
has been widely used to estimate body composition 
and in particular the body fat content in clinical set-
ting. However, BIA lacks the specifi city and accuracy 
since it is based on measuring diff erences in resistance 
as the electrical current passes through fatty and lean 
components of the body. Th e resistance between the 
conductors will provide a measurement of body fat 
since resistance to the conduction of electricity varies 
between adipose, muscular and skeletal tissue. Fat-free 
mass (muscle) is a good conductor as it contains a large 
amount of water and electrolytes, while fat being an-
hydrous behaves as a poor conductor20. Recently, a 
newer and more accurate methodological variant, the 
bioelectrical impedance vector analysis (BIVA), has 
been used to successfully identify the relative propor-
tion of fat mass in a large sample of adults21. Despite a 
nearly 50-year tradition of ultrasound usage to assess 
body fat in addition to many other body composition 
techniques, this method has not been adopted. Ultra-
sound can provide a site-specifi c evaluation of the skin, 
adipose tissue and muscle thicknesses, and it is being 
increasingly used to discriminate between visceral and 
subcutaneous adipose tissue. A comparison of the body 
fat measurements using a portable ultrasound to those 
measured by the calipers of the skinfold technique 
demonstrated no signifi cant diff erences. Moreover, the 
ultrasound procedure was shown to be faster and more 
cost eff ective than the other laboratory methods. Th e 
biggest limitations of using ultrasound as a body com-
position technique appear to be the lack of standard-
ization in the measurement technique and the results 
highly dependent on the operator profi ciency. Th ere-
fore, the availability of new, user-friendly devices with 
the accompanying software, designed specifi cally for 
body composition analysis, may be desirable in the fu-
ture22,23.
Furthermore, several other less available techniques 
have also been suggested, such as air displacement 
plethysmography (ADP), dual energy x-ray absorpti-
ometry (DXA), computed tomography (CT) and 
magnetic resonance imaging (MRI). Th ese techniques 
can provide the most accurate data on the fat mass and 
off er better quantitative assessment of visceral adipos-
ity compared to previous general and abdominal obe-
sity anthropometric measures. ADP and DXA can 
provide precise measures of fat mass but can only indi-
rectly evaluate visceral adiposity by monitoring chang-
es in pressure within a closed chamber or by measuring 
the total body and trunk fat masses24. For overweight 
and obese patients, ADP was found to be a valid mea-
sure of fat mass, fat-free mass and percent body fat 
when compared with values determined by the DXA 
criterion25. DXA is a simple noninvasive method with 
short-scanning time and virtually no radiation, which 
can accurately measure body composition and visceral 
fat with high precision and help defi ne the cardiovas-
cular risk and the risk of diabetes26. Currently, x-ray, 
CT or MRI present valuable methods and the refer-
ence standard for studying fat deposition by providing 
images that generate the most accurate, very specifi c 
and comprehensive data, which can be used to directly 
assess visceral adiposity24. A CT scan allows separate 
assessment of subcutaneous and visceral fat and the 
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visceral fat area from a single CT slice. At the L4 level, 
it signifi cantly correlates with the total visceral fat vol-
ume measured by the multi-slice CT scan27. Th e adi-
pose tissue MRI technique provides a reliable, quanti-
tative and noninvasive evaluation of central obesity, 
which is feasible in a clinical setting because it permits 
rapid and accurate assessment of the total and visceral 
adipose tissue. Th is can play a central role in the meta-
bolic syndrome risk assessment, as well as in the vis-
ceral/total fat tissue ratio28.
Th e Mechanisms Linking Obesity 
to Male Infertility
Th e exact pathophysiology underlying the infl u-
ence of obesity on the male reproductive potential in 
humans is still a matter of debate, as several possible 
mechanisms including hormonal, genetic or epigene-
tic, environmental or physical factors can play a role in 
addition to the negative eff ects of obesity per se14.
Th e reproductive hormone profi les of most obese 
men deviate from what is considered the norm. Vis-
ceral obesity is more likely to lead to changes in hor-
mone levels than fat stored in other parts of the body 
because white adipose tissue is a major endocrine or-
gan that secretes a number of biologically active pep-
tides and proteins including adipose-derived hor-
mones and adipokines. Due to obesity and the in-
creased infl ux of white adipose tissue, obese men tend 
to present with elevated estradiol and low testosterone 
levels because excess adipose tissue can possibly lead to 
increased aromatization of testosterone. Th e severity of 
obesity determines the degree to which the levels of 
estradiol are increased, accompanied by decreased tes-
tosterone, SHBG and inhibin B levels. It is suggested 
that elevated estrogen concentrations resulting from 
the increased conversion of androgens into estrogens 
may be explained by the overactivity of the aromatase 
cytochrome P450 enzyme, which is expressed at high 
levels in white adipose tissue. Th e increase in estrogen 
and decrease in testosterone levels, in addition to low-
ered levels of inhibin B, deleteriously aff ect spermato-
genesis and testicular function locally. Furthermore, 
high estrogen levels contribute to the negative feed-
back eff ect in the hypothalamus leading to decreased 
pulses of gonadotropin-releasing hormone (GnRH) 
and consequently decreased release of follicle-stimu-
lating hormone (FSH) and luteinizing hormone (LH). 
Th erefore, it seems that dysregulation of the hypotha-
lamic-pituitary-gonadal (HPG) axis as a consequence 
of male obesity might further explain the increased 
risks of sperm disorders and infertility7,29-31. Another 
key hormone produced by white adipose tissue is 
leptin the production of which increases with the 
amount of body fat and which plays a pivotal role in 
regulating the energy intake and expenditure. In the 
hypothalamus, leptin mainly targets its receptors by 
counteracting the eff ects of neuropeptide Y and mod-
ulating GnRH function through glutamate signaling 
or through a recently identifi ed hormone called kiss-
peptin. Under normal conditions, leptin acts at all lev-
els of the HPG axis increasing the production of 
GnRH and gonadotropins, stimulating steroidogene-
sis in Leydig cells, and increasing spermatogenesis by 
stimulating the activity of Sertoli cells. However, most 
of the obese individuals become insensitive to in-
creased leptin production and develop hormonal resis-
tance, which enables its stimulatory eff ects on the hy-
pothalamic neurons and the resultant pituitary secre-
tion of gonadotropins. Th erefore, hyperleptinemia in 
males with obesity as a consequence of GnRH/FSH/
LH disruption may contribute to aromatase overactiv-
ity in reducing testosterone levels and decreasing sper-
matogenesis resulting in hypogonadism and subfertil-
ity32,33. Furthermore, insulin, another important medi-
ator and modulator of the HPG axis beside leptin, has 
recently been reported as a contributing factor in the 
regulation of the male reproductive potential. As key 
stimulatory players, both hormones have demonstrat-
ed a direct or indirect eff ect on GnRH, LH and FSH 
centrally and on Leydig and Sertoli cell function lo-
cally. However, obesity is associated with increased se-
rum and seminal insulin and leptin concentrations, 
which may additionally impact the male reproductive 
capacity leading to decreased sperm concentration and 
sperm vitality, and increased sperm mitochondrial 
membrane potential and DNA fragmentation33,34. In 
contrast to leptin, currently available data suggest a 
largely inhibitory role of adiponectin on the hypo-
thalamus, pituitary and male gonads, however, circu-
lating levels of adiponectin are often decreased in obe-
sity33,35. Furthermore, a number of various adipokines 
at higher concentrations from excess white adipose 
tissue have been linked to male infertility. It was shown 
that two adipocyte-released adipokines (tumor necro-
sis factor-a and interleukin-6) signifi cantly reduced 
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human sperm progressive motility in a dose- and time-
dependent manner, by promoting the elevation of ni-
tric oxide production to pathological levels36. More-
over, increased release of adipokines results in infl am-
mation and can have a toxic eff ect on spermatozoa 
through the release of excess reactive oxygen species 
and reactive nitrogen species37.
Several syndromes including Klinefelter, Prader-
Willi, Laurence-Moon-Bardet-Biedel, Prader-Willi 
and Alström due to diff erent genetic abnormalities, 
display to various degrees, both obesity and infertili-
ty38. Furthermore, aromatase polymorphism may in-
fl uence the levels of estradiol in men by diff erentially 
modulating the quantitatively greater eff ects of obesity. 
Th is could explain why only certain obese men experi-
ence this rise in estradiol and subsequent fertility 
problems, whereas others experience no fertility is-
sues39. Moreover, factors secreted by the adipose tissue 
are able to alter the epigenetic regulation of genes by 
which the body responds to environmental pressures 
critical to the reproductive function40.
A growing number of reports suggest that chemi-
cal and physical agents in the environment, introduced 
and spread by human activity, may negatively aff ect 
male fertility. Most environmental contaminants are 
lipophilic and accumulate in fatty tissue around the 
scrotum and testes or elsewhere in the body. Epide-
miological studies evaluating the impact of environ-
mental exposures to pesticides, phthalates, polychlori-
nated biphenyls (PCBs), air pollution, trihalomethanes 
and mobile phones on semen quality suggest aware-
ness of environmental factors which may have a detri-
mental eff ect on the semen quality41. Although PCBs 
were banned by most countries several decades ago, 
the general population continues to be exposed due to 
their persistence and bioaccumulation and therefore 
concerns regarding the altered male fertility in relation 
to PCBs remain present42. Although the results of 
studies analyzing the impact of pesticides on male fer-
tility are not consistent, it seems that pesticide expo-
sure may aff ect spermatogenesis, leading to poor se-
men quality and reduced reproductive potential43. 
Many obese men with increased visceral fat distribu-
tion have a higher level of scrotal fat and this can in 
conjunction with a more sedentary lifestyle lead to 
increased testicular temperature. Elevation of scrotal 
temperature is one of the major factors that impairs 
spermatogenesis and steroidogenesis in testis with 
varicocele and is associated with reduced sperm motil-
ity, increased sperm DNA damage and increased 
sperm oxidative stress. Th erefore, thermoregulatory 
failure leading to testicular heat stress can compromise 
sperm quality and increase the risk of infertility 
through the molecular mechanisms including apopto-
sis, DNA damage and autophagy44. On assessing the 
functional thermal impairment secondary to varico-
cele, the scrotal thermoregulatory model indicates that 
varicocele alters the local heat exchange processes be-
tween cutaneous layers and inner structures45. Al-
though no overall association may be observed be-
tween regular physical activity and semen quality, bicy-
cling at levels of ≥5 hours per week has been associated 
with a reduced sperm concentration and total sperm 
count46.
Treatment
Given the apparent correlation between obesity 
and male infertility, treatment approaches should pri-
marily focus on the management of obesity and the 
obesity-related health issues. Th is can include lifestyle 
modifi cations, pharmacological interventions and sur-
gical options. Moreover, treatments are available not 
only for infertility related to obesity, but also as a treat-
ment for other comorbidities arising from obesity14. 
Lifestyle changes that lead to weight loss include diet 
modifi cations, as well as making conscious eff orts to 
exercise more in order to achieve a normal energy bal-
ance. Natural weight loss is the cornerstone and regu-
lar exercise the fi rst-line treatment of obesity-related 
infertility. Although reduction in body weight is 
 mostly associated with a consistent increase in SHBG, 
testosterone, LH and FSH levels and a reduction in 
estradiol, not much is known about the impact of diet/
exercise interventions on the semen parameters in 
obese men47. In the fi rst cohort study of 44 severely 
obese men having participated in a 14-week weight 
loss program, weight loss was associated with an in-
crease in total sperm count and semen volume in ad-
dition to improvement in testosterone, SHBG and 
anti-müllerian hormone levels48. Pharmacological 
methods employed in obesity-related male subfertility 
include the use of several drugs, such as aromatase in-
hibitors, estrogen receptor modulators, gonadotropins, 
phosphodiesterase inhibitors, and insulin-sensitizing 
agents49. Among them, aromatase inhibitors represent 
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a highly eff ective option, which was successfully used 
in several case series with promising results. However, 
aromatase inhibitors, as well as estrogen receptor mod-
ulators, are not licensed for the treatment of male hy-
pogonadism and/or infertility and therefore these 
treatments should be considered experimental until 
the ongoing clinical trials report their outcomes50-52. In 
conclusion, to date, there is no evidence-based treat-
ment that increases the likelihood of pregnancy when 
it comes to men with obesity-induced infertility49. 
Among surgical interventions that are used in the 
treatment of infertility in obese men, the outcome of 
in vitro fertilization in mildly obese individuals was 
more favorable in comparison to severe or morbidly 
obese (BMI ≥40 kg/m2) patients, as evidenced by low-
er pregnancy rates53. Th erefore, for individuals who are 
severely obese or who have failed to lose suffi  cient 
weight after dietary modifi cations and pharmacologi-
cal treatment, bariatric surgery is recommended as the 
most reliable treatment of obesity54. Although natural 
weight loss is the cornerstone in the treatment of obe-
sity-related infertility, with promising results in restor-
ing fertility and normal hormonal profi les, bariatric 
surgery results in greater improvements in terms of 
weight loss outcomes and weight associated comor-
bidities when compared with other non-surgical inter-
ventions. However, the impact of bariatric surgery on 
male fertility, pregnancy and miscarriage rates, as well 
as optimal timing of pregnancy is still unclear and 
therefore well structured clinical trials and further re-
search are necessary to answer these questions14,55,56.
Conclusion
In recent years, the worldwide obesity pandemic 
has grown to concerning proportions. Th e negative 
impact of obesity on the reproductive potential of male 
partner has been studied to a lesser extent. Although 
no consensus has been reached, numerous studies 
clearly show that male obesity is associated with re-
duced fertility in men due to hormonal, genetic, physi-
cal and environmental mechanisms which ultimately 
lead to abnormal semen parameters. In the manage-
ment of obesity-related male infertility, natural weight 
loss is the cornerstone and regular exercise the fi rst-
line treatment. Although bariatric surgery results in 
greater improvements in terms of weight loss out-
comes in comparison to non-surgical interventions, 
further investigations are required to clarify its infl u-
ence on male fertility.
References
 1. Hruby A, Hu FB. Th e epidemiology of obesity: a big picture. 
Pharmacoeconomics. 2015;33:673-89. doi: 10.1007/s40273-
014-0243-x.
 2. Ng M, Fleming T, Robinson M, Th omson B, Graetz N, Mar-
gono C, et al. Global, regional, and national prevalence of over-
weight and obesity in children and adults during 1980-2013: a 
systematic analysis for the Global Burden of Disease Study 
2013. Lancet. 2014;384:766-81. doi: 10.1016/S0140-6736(14)
60460-8.
 3. Nguyen DM, El-Serag HB. Th e epidemiology of obesity. Gas-
troenterol Clin North Am. 2010;39:1-7. doi: 10.1016/j.gtc.
2009.12.014.
 4. Pinborg A, Gaarslev C, Hougaard CO, Nyboe Andersen A, 
Andersen PK, Boivin J, et al. Infl uence of female bodyweight 
on IVF outcome: a longitudinal multicentre cohort study of 
487 infertile couples. Reprod Biomed Online. 2011;23:490-9. 
doi: 10.1016/j.rbmo.2011.06.010.
 5. Talmor A, Dunphy B. Female obesity and infertility. Best Pract 
Res Clin Obstet Gynaecol. 2015;29:498-506. doi: 10.1016/j.
bpobgyn.2014.10.014.
 6. MacDonald AA, Herbison GP, Showell M, Farquhar CM. Th e 
impact of body mass index on semen parameters and reproduc-
tive hormones in human males: a systematic review with meta-
analysis. Hum Reprod Update. 2010;16:293-311. doi: 10.1093/
humupd/dmp047.
 7. Aggerholm AS, Th ulstrup AM, Toft G, Ramlau-Hansen CH, 
Bonde JP. Is overweight a risk factor for reduced semen quality 
and altered serum sex hormone profi le? Fertil Steril. 2008;
90:619-26.
 8. Macdonald AA, Stewart AW, Farquhar CM. Body mass index 
in relation to semen quality and reproductive hormones in New 
Zealand men: a cross-sectional study in fertility clinics. Hum 
Reprod. 2013;28:3178-87. doi: 10.1093/humrep/det379.
 9. Sermondade N, Faure C, Fezeu L, Steegers-Th eunissen RP, 
Zorn B, Polotsky AJ, et al. BMI in relation to sperm count: an 
updated systematic review and collaborative meta-analysis. 
Hum Reprod Update. 2013;19:221-31. doi: 10.1093/humupd/
dms050.
10. Dupont C, Faure C, Sermondade N, Boubaya M, Eustache F, 
Clément P. Obesity leads to higher risk of sperm DNA damage 
in infertile patients. Asian J Androl. 2013;15:622-5. doi: 
10.1038/aja.2013.65.
11. Eisenberg ML, Kim S, Chen Z, Sundaram R, Schisterman EF, 
Buck Louis GM. Th e relationship between male BMI and 
waist circumference on semen quality: data from the LIFE 
study. Hum Reprod. 2014;29:193-200. doi: 10.1093/humrep/
det428.
M. Kasum et al. Male obesity and fertility
Acta Clin Croat, Vol. 55, No. 2, 2016 307
12. Corona G, Rastrelli G, Filippi S, Vignozzi L, Mannucci E, 
Maggi M. Erectile dysfunction and central obesity: an Italian 
perspective. Asian J Androl. 2014;16:581-91. doi: 10.4103/
1008-682X.126386.
13. McPherson NO, Lane M. Male obesity and subfertility, is it 
really about increased adiposity? Asian J Androl. 2015;17:
450-8. doi: 10.4103/1008-682X.148076.
14. Cabler S, Agarwal A, Flint M, Du Plessis SS. Obesity: modern 
man’s fertility nemesis. Asian J Androl. 2010;12:480-9. doi: 
10.1038/aja.2010.38.
15. Popkin BM. Recent dynamics suggest selected countries catch-
ing up to US obesity. Am J Clin Nutr. 2010;91:284-8. doi: 
10.3945/ajcn.2009.28473C.
16. Pasco JA, Nicholson GC, Brennan SL, Kotowicz MA. Preva-
lence of obesity and the relationship between the body mass 
index and body fat: cross-sectional, population-based data. 
PLoS One. 2012;7:e29580. doi: 10.1371/journal.pone.0029580.
17. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and 
not body mass index explains obesity-related health risk. Am J 
Clin Nutr. 2004;79:379-84.
18. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body 
mass index, waist circumference and waist:hip ratio as predic-
tors of cardiovascular risk – a review of the literature. Eur J Clin 
Nutr. 2010;64:16-22. doi: 10.1038/ejcn.2009.68
19. Carmienke S, Freitag MH, Pischon T, Schlattmann P, Fankhae-
nel T, Goebel H, et al. General and abdominal obesity param-
eters and their combination in relation to mortality: a system-
atic review and meta-regression analysis. Eur J Clin Nutr. 
2013;67:573-85. doi: 10.1038/ejcn.2013.61.
20. Th ibault R, Pichard C. Th e evaluation of body composition: a 
useful tool for clinical practice. Ann Nutr Metab. 2012;60:
6-16. doi: 10.1159/000334879.
21. Buff a R, Saragat S, Cabras S, Rinaldi AC, Marini E. Accuracy 
of Specifi c BIVA for the assessment of body composition in the 
United States population. PLoS One. 2013;8:e58533. doi: 
10.1371/journal.pone.0058533.
22. Wagner DR. Ultrasound as a tool to assess body fat. J Obes. 
2013;2013:280713. doi: 10.1155/2013/280713
23. Ulbricht L, Neves EB, Ripka WL, Romaneli EF. Comparison 
between body fat measurements obtained by portable ultrasound 
and caliper in young adults. Conf Proc IEEE Eng Med Biol Soc. 
2012;2012:1952-5. doi: 10.1109/EMBC.2012.6346337.
24. Shuster A, Patlas M, Pinthus JH, Mourtzakis M. Th e clinical 
importance of visceral adiposity: a critical review of methods 
for visceral adipose tissue analysis. Br J Radiol. 2012;85:1-10. 
doi: 10.1259/bjr/38447238.
25. Wingfi eld HL, Smith-Ryan AE, Woessner MN, Melvin MN, 
Fultz SN, Graff  RM. Body composition assessment in over-
weight women: validation of air displacement plethysmogra-
phy. Clin Physiol Funct Imaging. 2014;34:72-6. doi: 10.1111/
cpf.12067.
26. Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Sha-
piro MD, et al. Dual-energy x-ray absorptiometry for quantifi -
cation of visceral fat. Obesity (Silver Spring). 2012;20:1313-8. 
doi: 10.1038/oby.2011.393.
27. Ryo M, Kishida K, Nakamura T, Yoshizumi T, Funahashi T, 
Shimomura I. Clinical signifi cance of visceral adiposity as-
sessed by computed tomography: a Japanese perspective. World 
J Radiol. 2014;6:409-16. doi: 10.4329/wjr.v6.i7.409.
28. Poonawalla AH, Sjoberg BP, Rehm JL, Hernando D, Hines 
CD, Irarrazaval P, et al. Adipose tissue MRI for quantitative 
measurement of central obesity. J Magn Reson Imaging. 
2013;37:707-16. doi: 10.1002/jmri.23846
29. Ruige JB. Does low testosterone aff ect adaptive properties of 
adipose tissue in obese men? Arch Physiol Biochem. 2011;
117:18-22. doi: 10.3109/13813455.2010.525239.
30. Katib A. Mechanisms linking obesity to male infertility. Cent 
Eur J Urol. 2015;68:79-85. doi: 10.5173/ceju.2015.01.435.
31. Du Plessis SS, Cabler S, McAlister DA, Sabanegh E, Agarwal 
A. Th e eff ect of obesity on sperm disorders and male infertility. 
Nat Rev Urol. 2010;7:153-61. doi: 10.1038/nrurol.2010.6.
32. Landry D, Cloutier F, Martin LJ. Implications of leptin in neu-
roendocrine regulation of male reproduction. Reprod Biol. 
2013;13:1-14. doi: 10.1016/j.repbio.2012.12.001
33. Comninos AN, Jayasena CN, Dhillo WS. Th e relationship be-
tween gut and adipose hormones, and reproduction. Hum Re-
prod Update. 2014;20:153-74. doi: 10.1093/humupd/dmt033.
34. Leisegang K, Bouic PJ, Menkveld R, Henkel RR. Obesity is 
associated with increased seminal insulin and leptin alongside 
reduced fertility parameters in a controlled male cohort. 
Reprod Biol Endocrinol. 2014;12:34-9. doi: 10.1186/1477-
7827-12-34.
35. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endo-
crine organ. Mol Cell Endocrinol. 2010;316:129-39. doi: 
10.1016/j.mce.2009.08.018.
36. Lampiao F, du Plessis SS. TNF-alpha and IL-6 aff ect human 
sperm function by elevating nitric oxide production. Reprod 
Biomed Online. 2008;17:628-31. doi: 10.1016/j.mce.2009.
08.018.
37. Fraczek M, Kurpisz M. Infl ammatory mediators exert toxic ef-
fects of oxidative stress on human spermatozoa. J Androl. 
2007;28:325-33.
38. Kasturi SS, Tannir J, Brannigan RE. Th e metabolic syndrome 
and male infertility. J Androl. 2008;29:251-9. doi: 10.2164/jan-
drol.107.003731.
39. Hammoud A, Carrell DT, Meikle AW, Xin Y, Hunt SC, Adams 
TD, et al. An aromatase polymorphism modulates the relation-
ship between weight and estradiol levels in obese men. Fertil 
Steril. 2010;94:1734-8. doi: 10.1016/j.fertnstert.2009.10.037
40. Crujeiras AB, Casanueva FF. Obesity and the reproductive sys-
tem disorders: epigenetics as a potential bridge. Hum Reprod 
Update. 2015;21:249-61. doi: 10.1093/humupd/dmu060.
41. Jurewicz J, Hanke W, Radwan M, Bonde JP. Environmental 
factors and semen quality. Int J Occup Med Environ Health. 
2009;22:305-29. doi: 10.2478/v10001-009-0036-1.
M. Kasum et al. Male obesity and fertility
308 Acta Clin Croat, Vol. 55, No. 2, 2016
42. Meeker JD, Hauser R. Exposure to polychlorinated biphenyls 
(PCBs) and male reproduction. Syst Biol Reprod Med. 
2010;56:122-31. doi: 10.3109/19396360903443658.
43. Roeleveld N, Bretveld R. Th e impact of pesticides on male fer-
tility. Curr Opin Obstet Gynecol. 2008;20:229-33. doi: 
10.1097/GCO.0b013e3282fcc334.
44. Durairajanayagam D, Agarwal A, Ong C. Causes, eff ects and 
molecular mechanisms of testicular heat stress. Reprod Biomed 
Online. 2015;30:14-27. doi: 10.1016/j.rbmo.2014.09.018.
45. Mariotti A, Di Carlo L, Orlando G, Corradini ML, Di Do-
nato L, Pompa P, et al. Scrotal thermoregulatory model and 
assessment of the impairment of scrotal temperature control in 
varicocele. Ann Biomed Eng. 2011;39:664-73. doi: 10.1007/
s10439-010-0191-3.
46. Wise LA, Cramer DW, Hornstein MD, Ashby RK, Missmer 
SA. Physical activity and semen quality among men attending 
an infertility clinic. Fertil Steril. 2011;95:1025-30. doi: 
10.1016/j.fertnstert.2010.11.006.
47. Corona G, Rastrelli G, Monami M, Saad F, Luconi M, Luc-
chese M, et al. Body weight loss reverts obesity-associated hy-
pogonadotropic hypogonadism: a systematic review and meta-
analysis. Eur J Endocrinol. 2013;168:829-43. doi: 10.1530/
EJE-12-0955.
48. Håkonsen LB, Th ulstrup AM, Aggerholm AS, Olsen J, Bonde 
JP, Andersen CY, et al. Does weight loss improve semen quality 
and reproductive hormones? Results from a cohort of severely 
obese men. Reprod Health. 2011;8:24. doi: 10.1186/1742-
4755-8-24.
49. Hammoud AO, Meikle AW, Reis LO, Gibson M, Peterson 
CM, Carrell DT. Obesity and male infertility: a practical ap-
proach. Semin Reprod Med. 2012;30:486-95. doi: 10.1055/
s-0032-1328877.
50. Loves S, Ruinemans-Koerts J, de Boer H. Letrozole once a 
week normalizes serum testosterone in obesity-related male 
hypogonadism. Eur J Endocrinol. 2008;158:741-7. doi: 
10.1530/EJE-07-0663.
51. Stephens SM, Polotsky AJ. Big enough for an aromatase in-
hibitor? How adiposity aff ects male fertility. Semin Reprod 
Med. 2013;31:251-7. doi: 10.1055/s-0033-1345272.
52. Stokes VJ, Anderson RA, George JT. How does obesity aff ect 
fertility in men – and what are the treatment options? Clin 
Endocrinol (Oxf ). 2015;82:633-8. doi: 10.1111/cen.12591
53. Awartani KA, Nahas S, Al Hassan SH, Al Deery MA, Coskun 
S. Infertility treatment outcome in subgroups of obese popula-
tion. Reprod Biol Endocrinol. 2009;27:7:52. doi: 10.1186/1477-
7827-7-52.
54. Encinosa WE, Bernard DM, Chen CC, Steiner CA. Health-
care utilization and outcomes after bariatric surgery. Med Care. 
2006;44:706-12.
55. Reis LO, Dias FG. Male fertility, obesity, and bariatric sur-
gery. Reprod Sci. 2012;19:778-85. doi: 10.1177/1933719112
440053.
56. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for 
weight loss in adults. Cochrane Database Syst Rev. 2014 
CD003641. doi: 10.1002/14651858.CD003641.pub4.
Sažetak
UTJECAJ MUŠKE DEBLJINE NA PLODNOST
M. Kasum, S. Anić-Jurica, E. Čehić, T. Klepac-Pulanić, J. Juras i K. Žužul
Svrha ove studije bila je analizirati današnje dijagnostičke metode debljine kod odraslih muškaraca, potencijalne meha-
nizme koji povezuju debljinu s neplodnošću i mogućnosti liječenja s ciljem poboljšanja reprodukcijskog zdravlja. Debljina je 
širom svijeta poprimila epidemijski karakter s procijenjenom pojavnošću u porastu od 28,8% do 36,9% između 1980. i 2013. 
godine. U pogledu dijagnoze pretilosti razvijene su brojne jednostavne tehnike uključujući indeks tjelesne mase, omjer struka 
i kukova, opseg struka, analiza biolektričnog otpora, ultrazvuk i mjerenje kožnih nabora. Uz to, postoji nekoliko drugih rjeđe 
dostupnih no preciznijih tehnika kao što su pletizmografi ja na temelju istiskivanja zraka, apsorciometrija s dva izvora zrače-
nja, kompjutorizirana tomografi ja i magnetska rezonancija. Uz kardiovaskularne i druge bolesti pretilost muškarca može se 
nepovoljno odražavati na njegovu fertilnu sposobnost poremećajem razine reprodukcijskih hormona, smanjenom kvalitetom 
sjemena, pojačanim lučenjem hormona i masnog tkiva i adipokina, a isto tako kroz toplinske, genetske i spolne mehanizme. 
Pri vođenju neplodnosti muškarca povezane s pretilošću odlučujuće je prirodno smanjenje tjelesne težine, a redovite tjelo-
vježbe predstavljaju prvu liniju liječenja. Premda su kirurški zahvati na želucu i crijevima znatno uspješniji glede ishoda 
smanjenja tjelesne težine u odnosu na neoperacijske metode, potrebna su daljnja istraživanja za razjašnjenje njihovog utje caja 
na plodnost muškarca.
Ključne riječi: Muškarac; Debljina – dijagnoza; Debljina – komplikacije; Neplodnost, muška – terapija
